NEW YORK (Reuters) - a federal survey of the Food and Drug Administration insiders is expanded to look at other government employees, the Wall Street Journal reported Thursday, citing people familiar with the case.
The Securities and Exchange Commission has added a new charge against a former chemist of the FDA, Cheng Yi Liang, that she and the Department of Justice accused in March of the use of information on approvals of the drug to reap millions in profits for insiders.
Another person, the Ministry of Justice has requested information, the survey expanded is a second scientist to the FDA, the newspaper reported, citing sources familiar with the case.
People familiar with the case said authorities believe Liang of the alleged activities could have involved other people, including federal employees, according to the newspaper.
The Government focuses on one of these people helped Liang, took advantage of his trades, or independently began negotiation of their based on his information, the newspaper reported.
A lawyer for Liang was not immediately available for comment.
(Reported by Phil Wahba;) (Editing by Richard Chang)
没有评论:
发表评论